By: T.D. Thornton By unanimous voice vote, the New York State Gaming Commission (NYSGC) tweaked and augmented threshold levels for seven therapeutic Thoroughbred medications at the board’s Apr. 24 monthly meeting. According to a brief written by NYSGC general counsel Edmund Burns that was included in the informational packet for Monday’s meeting, the proposal will
By: Press Release An updated version (6.3) of the Association of Racing Commissioners International's Model Rules of Racing is now available on the association's website on the Model Rules and Standards page. (www.arci.com). The ARCI Model Rules represent the racing industry's best practice regulatory standards, developed in consultation with industry constituencies and adopted by the
NEWS RELEASE March 21, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD RECOMMENDS THERAPEUTIC WITHDRAWAL TIMES, GRANTS FIRST INTERIM LAB ACCREDITATION At its March 19 meeting in Baltimore, Maryland, the Racing Medication and Testing Consortium (RMTC) board of directors adopted recommendations for thresholds and withdrawal times for four therapeutic medications identified by the Association
NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC) board of directors addressed a number of important initiatives including therapeutic medications, laboratory proficiency, corticosteroid regulation and penalties for rule
NEWS RELEASE April 15, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC RECOMMENDS NEW PHENYLBUTAZONE THRESHOLD LEVEL, ANNOUNCES LAUNCH OF RECENT RULINGS DATABASE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has revised its recommended threshold for the non-steroidal anti-inflammatory drug (NSAID) phenylbutazone from 5
NEWS RELEASE October 1, 2009 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD FORMS COMMITTEE TO OVERSEE IMPLEMENTATION OF DTI TASK FORCE RECOMMENDATIONS Moving forward with its initiative to significantly change the structure of drug testing in U.S. horse racing, the Racing Medication and Testing Consortium (RMTC) board of directors has approved the formation of a
NEWS RELEASE February 12, 2009 Contact: Hallie Roach (859) 224-2848 SCIENTIFIC ADVISORY COMMITTEE, DRUG TESTING TASK FORCE PROVIDE UPDATES TO RMTC BOARD At their February 6 meeting in Las Vegas, Nevada, the Racing Medication and Testing Consortium (RMTC) board of directors heard important updates from their Scientific Advisory Committee and Drug Testing Initiatives Task Force.
During its meeting on Thursday, November 2, in Louisville, Ky., the board of directors of the Racing Medication and Testing Consortium (RMTC) announced future plans regarding anabolic steroids and out-of-competition drug testing, and received an update on ongoing projects related to the development of withdrawal times for therapeutic medications. The RMTC also announced it has